Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Oct '16 Oct '17 Oct '18 Oct '19 Oct '20 Oct '21 Oct '22 Oct '23 Oct '24 Oct '25
P/E ratio
30.90 31.94 64.79 22.35 45.17 39.46 32.94 24.50 29.35 31.96
Piotroski F-Score
8 8 7 5 5 7 7 6 5 5
P/S ratio
3.38 4.90 4.23 4.61 6.09 7.56 6.04 4.45 5.80 5.98
Altman Z-Score
4.71 4.90 4.39 4.05 5.08 6.69 6.17 5.15 5.07 5.46
Altman Z″-Score (non-manufacturers)
6.60 4.27 3.85 2.49 3.02 3.30 3.39 3.90 3.23 3.48
P/FCF ratio
21.72 30.72 22.83 27.47 40.50 36.87 40.64 20.66 27.58 36.02
Beneish M-Score
(2.64) (2.47) (2.79) (2.24) (2.48) (2.49) (2.34) (2.72) (2.64) (2.46)
P/Operating CF
60.70 76.06 55.91 75.75 86.26 108.27 92.34 58.90 78.57 76.27
Dividend Safety Score
— — — — — — — — — 86
P/B ratio
3.35 4.53 4.55 5.01 6.67 8.86 7.80 5.20 6.41 6.17
Price to Tangible BV
10.82 11.73 18.79 495.53 73.91 110.27 77.76 21.55 43.24 22.80
EV/Sales
3.29 4.70 4.14 4.69 6.25 7.74 6.29 4.62 6.11 6.16
EV/EBITDA
16.05 20.64 18.27 20.52 28.91 29.32 22.25 19.45 22.81 24.24
EV/Operating CF
17.43 23.65 18.72 23.70 36.22 32.93 32.81 17.80 22.73 27.47
EV/FCF
21.13 29.49 22.34 27.94 41.55 37.76 42.29 21.44 29.06 37.11
Quick Ratio
3.09 2.69 2.58 1.11 1.69 1.61 1.32 1.80 1.40 1.40
Current Ratio
3.85 3.30 3.29 1.53 2.33 2.22 2.03 2.61 2.09 1.96
Net Debt/EBITDA
(0.45) (0.86) (0.40) 0.35 0.73 0.69 0.87 0.71 1.16 0.71
Debt/Assets
24.43% 21.37% 21.06% 18.95% 23.72% 25.49% 25.95% 25.41% 28.24% 23.96%
Debt/Equity
0.45 0.37 0.39 0.38 0.47 0.51 0.52 0.47 0.57 0.45
Asset Turnover
0.55 0.55 0.58 0.57 0.56 0.62 0.64 0.64 0.58 0.57
Operating CF/Net income
1.72 1.30 3.44 0.95 1.28 1.23 1.05 1.43 1.36 1.20
Capex/Depreciation
(0.56) (0.83) (0.84) (0.66) (0.38) (0.59) (0.92) (1.10) (1.47) (1.41)
Interest Coverage
8.54 10.22 12.05 12.72 10.85 16.63 19.26 14.21 15.50 13.21
ROE
10.98% 15.06% 6.72% 22.99% 14.95% 23.58% 23.45% 22.24% 21.95% 20.62%
ROA
6.05% 8.43% 3.72% 11.90% 7.54% 11.90% 11.81% 11.65% 11.40% 10.61%
ROIC
9.96% 12.74% 13.70% 11.40% 9.25% 12.87% 14.48% 12.07% 11.75% 11.55%
Return on Tangible Assets
13.88% 18.67% 9.03% 54.67% 25.74% 39.86% 41.56% 32.18% 33.55% 30.52%
Average Days of Receivables
54.81 59.09 57.64 65.75 70.96 67.70 74.89 68.96 74.23 78.12
Research and Development Expense of Revenue
7.83% 7.63% 7.88% 7.82% 9.27% 6.98% 6.82% 7.04% 7.36% 6.55%
Selling, General and Administrative Expense of Revenue
29.82% 27.97% 28.27% 28.28% 28.02% 25.62% 23.90% 23.91% 24.09% 24.60%
Intangible Assets out of Total Assets
0.38 0.35 0.41 0.50 0.46 0.46 0.45 0.41 0.42 0.39
Share Based Compensation of Revenue
1.38% 1.34% 1.42% 1.39% 1.55% 1.74% 1.83% 1.62% 1.98% 1.84%
Graham Net Nets
0.01 0.03 (0.01) (0.06) (0.04) (0.03) (0.03) (0.02) (0.05) (0.03)
Graham Number
20.33 26.83 17.90 33.96 28.75 39.84 40.95 43.45 45.08 49.46
Earnings Yield
3.24% 3.13% 1.54% 4.48% 2.21% 2.53% 3.04% 4.08% 3.41% 3.13%
Free Cash Flow Yield
4.60% 3.25% 4.38% 3.64% 2.47% 2.71% 2.46% 4.84% 3.63% 2.78%
Revenue per Share
12.89 13.89 15.31 16.44 17.28 20.79 22.90 23.24 22.45 24.46
Operating CF per Share
2.43 2.76 3.39 3.25 2.98 4.88 4.39 6.03 6.04 5.49
Capex per Share
(0.43) (0.55) (0.55) (0.50) (0.38) (0.62) (0.97) (1.01) (1.30) (1.43)
Free Cash Flow per Share
2.01 2.21 2.84 2.75 2.60 4.27 3.41 5.01 4.73 4.06
Cash per Share
7.02 8.32 7.00 4.40 4.66 5.18 3.52 5.41 4.58 6.30
Shareholders Equity per Share
13.02 15.02 14.24 15.12 15.77 17.73 17.74 19.88 20.34 23.74
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
13.02 15.02 14.24 15.12 15.77 17.73 17.74 19.88 20.34 23.74
Free Cash Flow
654.00 713.00 911.00 865.00 803.00 1,297.00 1,021.00 1,474.00 1,373.00 1,152.00
Working Capital
2,690.00 2,906.00 2,677.00 1,109.00 1,948.00 2,091.00 1,917.00 2,583.00 2,064.00 2,247.00
Capital Expenditures
(139.00) (176.00) (176.00) (156.00) (118.00) (188.00) (291.00) (298.00) (378.00) (407.00)
Net Current Asset Value
87.00 578.00 (122.00) (1,515.00) (1,339.00) (1,517.00) (1,449.00) (732.00) (1,989.00) (1,392.00)
EV/EBIT
22.47 26.06 22.51 25.71 39.44 36.30 26.60 23.36 26.75 28.96
Capex to Sales
0.03 0.04 0.04 0.03 0.02 0.03 0.04 0.04 0.06 0.06
Price to Operating Income
23.10 27.14 23.01 25.28 38.44 35.45 25.57 22.51 25.40 28.10
Other line items
Depreciation/Fixed assets
0.39 0.28 0.26 0.28 0.36 0.34 0.29 0.21 0.14 0.14
Cash ROIC
7.75% 7.66% 10.57% 10.92% 9.34% 13.38% 11.23% 14.49% 12.99% 9.95%
Accounts Receivable Turnover
6.79 6.60 6.55 6.05 5.43 5.72 5.31 5.07 4.98 4.94
Accounts Payable Turnover
7.48 7.38 6.93 6.80 7.07 7.28 6.09 6.75 6.21 5.96
Inventory Turnover
3.73 3.74 3.68 3.58 3.58 3.76 3.35 3.26 2.97 3.31
Average Days of Payables
46.79 53.70 55.55 54.80 51.64 55.90 67.72 45.30 66.25 62.95
Days of Inventory on Hand
97.03 101.24 104.24 105.10 105.04 104.04 121.20 111.73 119.25 113.20
Average Receivables
618.50 677.50 750.00 853.00 984.00 1,105.00 1,288.50 1,348.00 1,307.50 1,405.50
Average Payables
268.00 281.00 322.50 347.00 354.00 400.00 513.00 499.00 479.00 555.00
Average Inventory
537.00 554.00 606.50 658.50 699.50 775.00 934.00 1,034.50 1,001.50 998.50
Average Assets
7,636.50 8,110.00 8,483.50 8,996.50 9,539.50 10,166.00 10,618.50 10,647.50 11,304.50 12,286.50
Average Common Equity
4,208.00 4,540.50 4,703.00 4,659.50 4,810.50 5,131.00 5,347.00 5,575.00 5,871.50 6,319.50

Fold the line items

Columns are period end dates